Purdue Pharma Has a New Plan to Settle Mass Opioid Lawsuits. Here’s What Happens Next.
Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...
Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement
Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid ...
Purdue Pharma asks bankruptcy judge to accept new settlement plan
Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the ...
Purdue Pharma Files New Reorganization Plan With $7.4 Billion for Creditors
The bankrupt drugmaker and OxyContin manufacturer will be dissolved and its assets transferred to a new company.
San Antonio Express-News10d
Purdue Pharma submits opioid lawsuit settlement plan, including up to $7 billion cash from Sacklers
Purdue Pharma asked a bankruptcy judge late Tuesday ... Superior HealthPlan’s CEO was reportedly fired after the inquiry was announced... The new entity would be run by a board appointed by ...
Business Wire11d
Purdue Pharma L.P. Files New Plan of Reorganization Providing for More Than $7.4 Billion in Creditor Distributions
--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today filed a Chapter 11 Plan of Reorganization (the “Plan”) and related disclosure statement with the United States Bankruptcy Court for ...
Kiii3 News10d
Sackler family to pay up to $7 billion cash under Purdue Pharma's new opioid settlement plan
WASHINGTON — Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller ...
The Associated Press on MSN10d
Purdue Pharma submits opioid lawsuit settlement plan, including up to $7 billion cash from Sacklers
Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...
Wall Street Journal10d
Purdue Pharma Files New Reorganization Plan With $7.4 Billion for Creditors
Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.